Elanco (ELAN) CFO Robert VanHimbergen Receives Award

What Happened

• Robert M. VanHimbergen, Executive Vice President and Chief Financial Officer of Elanco Animal Health Inc., was granted 8.788 deferred stock units on September 18, 2026. The units were valued at $22.42 each, totaling about $197. This was an award/grant (derivative) rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-09-18; grant type: Award/Grant (code A); price/value shown: $22.42 per unit; total value ≈ $197.
• Security: Deferred stock units (derivative); quantity: 8.788 units (each unit represents a right to one share or cash equivalent).
• Shares owned after the transaction: Not specified in the provided filing summary.
• Footnotes: F1 — each deferred stock unit equals the right to one share or cash equivalent. F2 — units settle in cash or shares after termination of employment or in a specified future year per the Executive Deferral and Stock Match Plan.
• Filing timeliness: Report filed 2026-09-22 for a 2026-09-18 transaction; this meets the Form 4 two-business-day filing requirement (timely).

Context

• This was a deferred award (not an immediate share purchase). Deferred stock units are commonly used for compensation or matching and do not necessarily indicate near-term buying or selling of shares. The units will convert to shares or cash later per the plan terms.